2021
DOI: 10.1007/s40520-021-01943-7
|View full text |Cite|
|
Sign up to set email alerts
|

The Montreal Cognitive Assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy

Abstract: Background The availability of fine-grained, culture-specific psychometric outcomes can favor the interpretation of scores of the Montreal Cognitive Assessment (MoCA), the most frequently used instrument to screen for mild cognitive dysfunctions in both instrumental and non-instrumental domains. This study thus aimed at providing: (i) updated, region-specific norms for the Italian MoCA, by also (ii) comparing them to pre-existing ones with higher geographical coverage; (iii) information on sensit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
89
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

5
4

Authors

Journals

citations
Cited by 67 publications
(95 citation statements)
references
References 48 publications
6
89
0
Order By: Relevance
“…The need for a more fine-grained adjustment for age, sex, and education in interpreting an individual’s performance of the MoCA has become even more important as the MoCA is increasingly being used in a variety of patient samples. While originally developed for the detection of MCI and dementia due to Alzheimer’s disease, the MoCA has been studied to assess cognitive deficits in patients with a variety of medical conditions [ 12 ], including HIV [ 13 ], Parkinson’s disease [ 14 ], multiple sclerosis [ 15 ], stroke [ 16 ], frontotemporal dementia [ 17 ], substance-related cognitive disorders [ 18 , 19 ], cardiac arrest [ 20 ], fibromyalgia [ 21 ], Huntington’s disease [ 22 ], syncope and unexpected falls [ 23 ], cerebellar disease [ 24 ], schizophrenia [ 25 ], sickle cell disease [ 26 ], type 2 diabetes [ 27 ], and COVID-19 [ 28 ]. Many of these conditions affect younger adults, who may perform above established cut-off scores based on samples of older individuals even when cognitive impairment is present.…”
Section: Introductionmentioning
confidence: 99%
“…The need for a more fine-grained adjustment for age, sex, and education in interpreting an individual’s performance of the MoCA has become even more important as the MoCA is increasingly being used in a variety of patient samples. While originally developed for the detection of MCI and dementia due to Alzheimer’s disease, the MoCA has been studied to assess cognitive deficits in patients with a variety of medical conditions [ 12 ], including HIV [ 13 ], Parkinson’s disease [ 14 ], multiple sclerosis [ 15 ], stroke [ 16 ], frontotemporal dementia [ 17 ], substance-related cognitive disorders [ 18 , 19 ], cardiac arrest [ 20 ], fibromyalgia [ 21 ], Huntington’s disease [ 22 ], syncope and unexpected falls [ 23 ], cerebellar disease [ 24 ], schizophrenia [ 25 ], sickle cell disease [ 26 ], type 2 diabetes [ 27 ], and COVID-19 [ 28 ]. Many of these conditions affect younger adults, who may perform above established cut-off scores based on samples of older individuals even when cognitive impairment is present.…”
Section: Introductionmentioning
confidence: 99%
“…The Finally, item-level information has been herein enclosed to help practitioners interpret test scores [2].…”
Section: Discussionmentioning
confidence: 99%
“…Table 3 presents the scores obtained at neuropsychological tests by MSA-P and -C patients. Overall, MoCA scores were within normal limits, with only one person reaching a borderline score, according to updated norms ( 38 ).…”
Section: Resultsmentioning
confidence: 96%